BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Han K, Kim JH, Ko GY, Gwon DI, Sung KB. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review. World J Gastroenterol 2016; 22(1): 407-416 [PMID: 26755886 DOI: 10.3748/wjg.v22.i1.407]
URL: https://www.wjgnet.com/1948-5182/full/v22/i1/407.htm
Number Citing Articles
1
Jun An, Zhigang Zhang, Zhiyong Liu, Ruizhi Wang, Dayang Hui, Yi Jin. Overexpression of Cullin7 is associated with hepatocellular carcinoma progression and pathogenesisBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3839-7
2
Zi-Wen Tao, Bao-Quan Cheng, Tao Zhou, Yan-Jing Gao. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative reviewHepatobiliary & Pancreatic Diseases International 2022; 21(2): 134 doi: 10.1016/j.hbpd.2021.12.004
3
Jack P. Silva, Nicholas G. Berger, Susan Tsai, Kathleen K. Christians, Callisia N. Clarke, Harveshp Mogal, Sarah White, William Rilling, T. Clark Gamblin. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysisHPB 2017; 19(8): 659 doi: 10.1016/j.hpb.2017.04.016
4
Yang Liu, Hongbo Zou, Qichao Xie, Lan Zou, Rui Kong, Bijing Mao. Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expressionBioMedical Engineering OnLine 2021; 20(1) doi: 10.1186/s12938-021-00903-6
5
Jing Chen, Di Wu, Yue Zhang, Yong Yang, Yunfei Duan, Yong An. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinomaClinical Science 2019; 133(2): 367 doi: 10.1042/CS20180814
6
Bo Liu, Tianyu Xiong, Jian Lu, Shengwei Li, Xiangzhi Bai, Fugen Zhou, Qiuwen Wu. Technical note: A fast and accurate analytical dose calculation algorithm for 125 I seed‐loaded stent applications Medical Physics 2021; 48(11): 7493 doi: 10.1002/mp.15207
7
Yue Yang, Pingya He, Ning Li. The Antitumor Potential of Extract of the Oak Bracket Medicinal Mushroom Inonotus baumii in SMMC-7721 Tumor CellsEvidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/1242784
8
In-Jung Kim, Sung Hwan Yoo, Jung Il Lee, Kwan Sik Lee, Hyun Woong Lee, Jin Hong Lim. Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case reportJournal of Liver Cancer 2022; 22(1): 84 doi: 10.17998/jlc.2022.03.07
9
Seongmoon Jung, Sui Shen, Sung-Joon Ye. Dose perturbation and inhomogeneity of multi-arrays of 125I seed-loaded stent for treatment of portal vein tumor thrombosisPhysica Medica 2019; 66: 1 doi: 10.1016/j.ejmp.2019.09.077
10
Yang Gao, Peng‐Xiang Wang, Jian‐Wen Cheng, Yun‐Fan Sun, Bo Hu, Wei Guo, Kai‐Qian Zhou, Yue Yin, Yuan‐Cheng Li, Jian Wang, Jun‐Feng Huang, Shuang‐Jian Qiu, Jian Zhou, Jia Fan, Xin‐Rong Yang. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score‐matched survival analysisCancer Medicine 2019; 8(16): 6933 doi: 10.1002/cam4.2556
11
Tao Sun, Lei Chen, Xuefeng Kan, Yanqiao Ren, Yanyan Cao, Weihua Zhang, Haohao Lu, Chuansheng Zheng, San Lin You. A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor ThrombusJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1255133
12
Maria Grazia Lucà, Roberto Nani, Melanie Schranz, Massimo De Giorgio, Claudia Iegri, Roberto Agazzi, Francesco Sala, Giorgio Virotta, Donatella Sarti, Grazia Conte, Domenico Pinelli, Carlo Nicora, Michele Colledan, Sandro Sironi, Stefano Fagiuoli. Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenibFuture Oncology 2018; 14(8): 727 doi: 10.2217/fon-2017-0566
13
Xinhua Zou, Wenzhe Fan, Miao Xue, Jiaping Li. Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) ProgressionCancer Management and Research 2021; : 4013 doi: 10.2147/CMAR.S304591
14
Jianchu Wang, Qianli Tang, Libai Lu, Zongjiang Luo, Wenchuan Li, Yuan Lu, Jian Pu. LncRNA OIP5-AS1 interacts with miR-363-3p to contribute to hepatocellular carcinoma progression through up-regulation of SOX4Gene Therapy 2020; 27(10-11): 495 doi: 10.1038/s41434-020-0123-2
15
Jun An, Zhiyong Liu, Qiong Liang, Yuhang Pan, Haifeng Li, Ruizhi Wang, Yi Jin. Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinomaHuman Pathology 2017; 67: 146 doi: 10.1016/j.humpath.2017.07.008
16
Jin Hyoung Kim, Ju Hyun Shim, Hyun‐Ki Yoon, Heung‐Kyu Ko, Jong Woo Kim, Dong Il Gwon. Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal veinLiver International 2018; 38(9): 1646 doi: 10.1111/liv.13719
17
Miao Chen, Duo Wang, Yuan Zhao, Dan‑Mei Lu, Hong‑Xue Li, Jun‑Jie Liu, Hang Li. Preoperative color Doppler ultrasonography predicts early recurrence in AFP‑positive hepatocellular carcinomaOncology Letters 2019;  doi: 10.3892/ol.2019.10825
18
Nokjung Kim, Myung-Won You. Hepatocellular carcinoma and macrovascular tumor thrombosis: treatment outcomes and prognostic factors for survivalJapanese Journal of Radiology 2019; 37(11): 781 doi: 10.1007/s11604-019-00868-6
19
Shunnan Yao, Jianpin Ye, Mengqi Yin, Rui Yu. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivoCancer Letters 2020; 483: 87 doi: 10.1016/j.canlet.2020.04.003
20
Junqing Lin, Han Jiang, Weizhu Yang, Na Jiang, Qubin Zheng, Ning Huang, Xiaolong Wang, Ang Li, Jingyao Huang. Predictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosisBrachytherapy 2019; 18(2): 233 doi: 10.1016/j.brachy.2018.10.002
21
Leandro Cardarelli-Leite, John Chung, Darren Klass, Vladimir Marquez, Frank Chou, Stephen Ho, Henry Walton, Howard Lim, Peter Tae Wan Kim, Anastasia Hadjivassiliou, David M. Liu. Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor ThrombusCardioVascular and Interventional Radiology 2020; 43(3): 411 doi: 10.1007/s00270-019-02404-5
22
Yi-Fan Wu, Tao Wang, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Fu-Liang He, Fu-Quan Liu. Stents combined with iodine-125 implantation to treat main portal vein tumor thrombusWorld Journal of Gastrointestinal Oncology 2018; 10(12): 496-504 doi: 10.4251/wjgo.v10.i12.496
23
Dong Hyun Kim, Eunae Cho, Sung Bum Cho, Sung Kyu Choi, Sunmin Kim, Jieun Yu, Young-Il Koh, Da Woon Sim, Chung Hwan Jun. Complete response of hepatocellular carcinoma with right atrium and pulmonary metastases treated by combined treatments (a possible treatment effect of natural killer cell)Medicine 2018; 97(42): e12866 doi: 10.1097/MD.0000000000012866
24
Pyeong Hwa Kim, Sang Hyun Choi, Jin Hyoung Kim, Seong Ho Park. Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and EfficacyKorean Journal of Radiology 2019; 20(3): 385 doi: 10.3348/kjr.2018.0496
25
Sumit Siddharth, Nethaji Muniraj, Neeraj Saxena, Dipali Sharma. Concomitant Inhibition of Cytoprotective Autophagy Augments the Efficacy of Withaferin A in Hepatocellular CarcinomaCancers 2019; 11(4): 453 doi: 10.3390/cancers11040453
26
Zhiwen Yang, Ruhai Zou, Yun Zheng, Jiliang Qiu, Jingxian Shen, Yadi Liao, Yuanping Zhang, Chenwei Wang, Yongjin Wang, Yichuan Yuan, Kai Li, Dinglan Zuo, Wei He, Wenwu Liu, Binkui Li, Yunfei Yuan. Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisationEuropean Radiology 2019; 29(11): 5752 doi: 10.1007/s00330-019-06157-0
27
Shuangxi Li, Lei Li, Baohua Li, Wenhui Wang. Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosisThe British Journal of Radiology 2020; 93(1112): 20190279 doi: 10.1259/bjr.20190279
28
Xiao-Chun Meng, Bing-Hui Chen, Jing-Jun Huang, Wen-Sou Huang, Ming-Yue Cai, Jing-Wen Zhou, Yong-Jian Guo, Kang-Shun Zhu. Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenibWorld Journal of Gastroenterology 2018; 24(4): 484-493 doi: 10.3748/wjg.v24.i4.484
29
Li-Hong Yao, Liang Su, Lu Liu, Hai-Tao Sun, Jun-Jie Wang. Stenting of the Portal Vein Combined with Different Numbers of Iodine-125 Seed StrandsChinese Medical Journal 2017; 130(18): 2183 doi: 10.4103/0366-6999.213974
30
Ghada H. Mansour, Mohammed A. El-Magd, Dalia H. Mahfouz, Ismail A. Abdelhamid, Magda F. Mohamed, Nada S. Ibrahim, Abdel Hady A. Abdel Wahab, Emad M. Elzayat. Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cellsBioorganic Chemistry 2021; 116: 105329 doi: 10.1016/j.bioorg.2021.105329
31
Lucia Cerrito, Brigida Eleonora Annicchiarico, Roberto Iezzi, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiersWorld Journal of Gastroenterology 2019; 25(31): 4360-4382 doi: 10.3748/wjg.v25.i31.4360
32
Su Ho Kim, Jung Suk Oh, Ho Jong Chun, Byung Gil Choi, Hae Giu Lee. Dual-Port versus Mono-Port Implantation for Intra-Arterial Chemoinfusion Therapy for Treatment of Hepatocellular Carcinoma in Patients with Anatomic Hepatic Artery VariationJournal of Vascular and Interventional Radiology 2019; 30(1): 23 doi: 10.1016/j.jvir.2018.06.006
33
Jenny Que, Hung-Chang Wu, Chia-Hui Lin, Chung-I Huang, Li-Ching Li, Chung-Han Ho. Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosisMedicine 2020; 99(13): e19660 doi: 10.1097/MD.0000000000019660
34
Tan Tan, Yudong Xiao, Shunke Zhou, Cong Ma, Zishu Zhang. Y-configuration stent combined with iodine-125 seeds strand for the treatment of hepatocellular carcinoma with tumor thrombosis in portal vein branchesMedicine 2017; 96(46): e8660 doi: 10.1097/MD.0000000000008660
35
Wen Peng Zhao, Honglu Li, Jiang Guo, Liang Cai, Youjia Duan, Xiaopu Hou, Hongliu Du, Xihong Shao, Zhenying Diao, Changqing Li. Hepatocellular carcinoma with type II–III portal vein tumour thrombosis: treatment using transarterial chemoembolisation and microwave ablationThe British Journal of Radiology 2021; 94(1117): 20200415 doi: 10.1259/bjr.20200415
36
Xiaojie Li, Zhimin Ye, Sheng Lin, Haowen Pang. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogramBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08469-1
37
Teng Li, Yun Liu, Yanming Sun. Long non-coding RNA AB209630 suppresses cell proliferation and metastasis in human hepatocellular carcinomaExperimental and Therapeutic Medicine 2017; 14(4): 3419 doi: 10.3892/etm.2017.4927
38
Chung Hwan Jun, Jae Hyun Yoon, Eunae Cho, Sang Soo Shin, Sung Bum Cho, Hee Joon Kim, Chang Hwan Park, Hyun Soon Kim, Sung Kyu Choi, Jong Sun Rew. Barcelona clinic liver cancer-stage C hepatocellular carcinomaMedicine 2017; 96(17): e6745 doi: 10.1097/MD.0000000000006745
39
Chun-San Tai, Yan-Ren Lin, Tsung-Han Teng, Ping-Yi Lin, Siang-Jyun Tu, Chih-Hung Chou, Ya-Rong Huang, Wei-Chih Huang, Shun-Long Weng, Hsien-Da Huang, Yao-Li Chen, Wen Liang Chen, William B. Coleman. Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinomaPLOS ONE 2017; 12(2): e0171269 doi: 10.1371/journal.pone.0171269
40
Yuhang Pan, Zhiyong Liu, Zhiying Feng, Dayang Hui, Xiangqi Huang, Dayue Tong, Yi Jin. The overexpression of Rabl3 is associated with pathogenesis and clinicopathologic variables in hepatocellular carcinomaTumor Biology 2017; 39(4): 101042831769623 doi: 10.1177/1010428317696230